Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells

Microvascular Research

Volumn 53, Issue 3, 1997, Pages 254-260

  Gualandris, Anna ^a   Conejo, Teresa Lopez ^b,c   Giunciuglio, Daniela ^b   Albini, Adriana ^b   Sabini, Elisabetta ^b   Rusnati, Marco ^a   Dell'Era, Patrizia ^a   Presta, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL INVASION; CONTROLLED STUDY; COW; ENDOTHELIUM CELL; FETUS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANIMALIA; BOVINAE;

EID: 0031149183     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1996.1998     Document Type: Article

References (29)

1. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aarondon, S. A., Kozlowski, J. M., and McEwan, R. N. (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47, 3239-3245.
2. Astedt, B., and Tropé, C. (1980). Effect of tranexamin acid on progress of experimental tumours and on DNA-synthesis. Experientia 36, 679-680.
3. Avery, R. L., Connor, T. B., and Farazdaghi, M. (1990). Systemic amiloride inhibits experimentally induced angiogenesis. Arch. Ophtalmol. 108, 1474-1476.
4. Bacharach, E., Itin, A., and Keshet, E. (1992). In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc. Natl. Acad. Sci. USA 89, 10686-10690.
5. Bastaki, M., Nelli, E. E., Dell'Era, P., Rusnati, M., Molinari-Tosatti, M. P., Parolini, S., Auerbach, R., Ruco, L. P., Possati, L. P., and Presta, M. (1996). Mouse endothelium and its response to basic fibroblast growth factor: A comparative study on different cell lines. Arterioscler. Thromb. Vascular Res., in press.
6. Berman, M., Winthrop, S., Ausprunk, D., Rose, J., Langer, R., and Gage, J. (1982). Plasminogen activator (urokinase) causes vascularization of the cornea. Invest. Ophtalmol. Vis. Sci. 22, 191-199.
7. Bugge, T. H., Flick, M. J., Daugherty, C. C., and Degen, J. L. (1995). Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Gene Dev. 9, 794-807.
8. Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., and Comoglio, P. M. (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119, 629-641.
9. Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De vos, R., van den Oord, J. J., Collen, D., and Mulligan, R. C. (1994). Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368, 419-424.
10. Corasanti, J. G., Hobika, G. H., and Markus, G. (1982). Interference with dimethylydrazine induction of colon tumors in mice by ∈-aminocaproic acid. Science 216, 1020-1021.
11. Fazioli, F., and Blasi, F. (1994). Urokinase-type plasminogen activator and its receptor: New targets for anti-metastatic therapy? Trends Pharmacol Sci. 15, 25-29.
12. Fibbi, G., Ziche, M., Morbidelli, L., Magnelli, L., and Del Rosso, M. (1988). Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp. Cell Res. 179, 385-395.
13. Grinspan, J. B., Stephen, N. M., and Levine, E. M. (1983). Bovine endothelial cells transformed in vitro with benzo(a)pyrene. J. Cell. Physiol. 114, 328-338.
14. Grondahl-Hansen, J., Kirkeby, L. T., Ralfkiaer, E., Kristensen, P., Lund, L. R., and Dano, K. (1989). Urokinase-type plasminogen activator in endothelial celld during acute inflammation of the appendix. Am. J. Pathol. 135, 631-636.
15. Gualandris, A., and Presta, M. (1995). Transcriptional and post-transcriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor. J. Cell. Physiol. 162, 400-409.
16. Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W., and Martin, G. R. (1986). Basement membrane complexes with biological activity. Biochemistry 25, 312-318.
17. Mandriota, S. J., Seghezzi, G., Vassalli, J.-D., Ferrara, N., Wasi, S., Mazzieri, R., Mignatti, P., and Pepper, M. (1995). Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J. Biol. Chem. 270, 9709-9716.
18. Mignatti, P., Tsuboi, R., Robbins, E., and Rifkin, D. B. (1989). In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108, 671-682.
19. Mignatti, P., Mazzieri, R., and Rifkin, D. B. (1991). Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J. Cell Biol. 113, 1193-1201.
20. Mignatti, P., and Rifkin, D. B. (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195.
21. Moscatelli, D., and Rifkin, D. B. (1988). Membrane and matrix localization of proteinases: A common theme in tumor cell invasion and angiogenesis. Biochem. Biophys. Acta 948, 67-85.
22. Odekon, L. E., Sato, Y., and Rifkin, D. B. (1992). Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J. Cell. Physiol. 150, 258-263.
23. Ossowski, L., Russo-Payne, H., and Wilson, E. L. (1991). Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse. Cancer Res. 51, 274-281.
24. Pepper, M., Ferrara, N., Orci, L., and Montesano, R. (1991). Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181, 902-906.
25. Pepper, M., Sappino, A.-P., Stocklin, R., Montesano, R., Orci, L., and Vassalli, J.-D. (1993). Upregulation of urokinase receptor expression on migrating endothelial cells. J. Cell Biol. 122, 673-684.
26. Saksela, O., and Rifkin, D. B. (1988). Cell-associated plasminogen activation: Regulation and physiological functions. Annu. Rev. Cell Biol. 4, 93-126.
27. Stetler-Stevenson, W., Krutzsch, H., Wacher, M., Margulies, M. K., and Liotta, L. A. (1989). The activation of human type IV collagenase proenzyme. J. Biol. Chem. 264, 1353-1356.
28. Teuscher, E., and Pester, E. A. (1984). A possible explanation of mechanisms inducing inhibition of vascularization of tumors by antifibrinolytic drugs: The influence of migratory behaviour of endothelial cells. Biomed. Biochim. Acta 43, 447-456.
29. Yasunaga, C., Nakashima, Y., and Sueishi, K. (1989). A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method. Lab. Invest. 61, 698-704.